Watchlist Manager

Watchlist

Price: 551 000 KRW 1.85% Market Closed

Market Cap: ₩7.1T

	Hanmi Pharm Co Ltd KRX:128940	KR
M	Maven Wireless Sweden AB STO:MAVEN	SE
	Shreyans Industries Ltd NSE:SHREYANIND	IN
	Vicor Corp NASDAQ:VICR	US
M	Military Commercial Joint Stock Bank VN:MBB	VN
	CONSOL Energy Inc NYSE:CEIX	US
R	Reserve Petroleum Co OTC:RSRV	US

Balance Sheet

Currency: KRW

	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024	Dec-2025
Assets
Cash & Cash Equivalents	18 234	38 065	24 922	18 960	21 627	55 160	69 298	52 471	138 329	130 372	47 266	67 338	106 113	146 157	209 225	147 329	54 980	192 278	108 274
Cash Equivalents	18 234	38 065	24 922	18 960	21 627	55 160	69 298	52 471	138 329	130 372	47 266	67 338	106 113	146 157	209 225	147 329	54 980	192 278	108 274
Short-Term Investments	1 816	1 154	312	252	9 761	32 056	40 406	45 420	44 197	199 831	93 119	31 358	1 979	1 874	85	88 212	199 175	110	92 467
Total Receivables	220 321	237 659	240 362	238 509	210 870	203 539	221 447	290 508	784 927	271 571	250 331	183 469	191 287	152 838	225 276	183 439	179 003	239 277	341 813
Accounts Receivables	219 040	234 052	232 968	237 029	208 145	200 925	218 331	286 172	777 726	250 515	247 739	177 851	185 557	145 243	222 701	181 579	176 221	238 260	340 077
Other Receivables	1 281	3 607	7 394	1 480	2 725	2 614	3 116	4 336	7 201	21 056	2 592	5 618	5 730	7 595	2 575	1 860	2 783	1 016	1 737
Inventory	69 708	98 937	116 523	116 868	108 243	116 463	105 792	133 069	158 143	190 381	232 124	247 755	326 727	308 538	250 189	266 185	288 914	300 995	338 792
Other Current Assets	12 667	14 786	39 388	6 126	12 972	9 653	14 829	16 251	19 524	48 587	35 251	34 173	36 098	4 965	19 188	8 994	8 551	13 647	12 603
Total Current Assets	322 747	390 601	421 508	380 715	363 473	416 871	451 772	537 719	1 145 121	840 742	658 091	564 093	662 204	614 373	703 962	694 158	730 624	746 306	893 949
PP&E Net	211 542	240 974	261 091	275 031	261 468	256 845	259 377	327 872	415 734	598 936	790 052	900 317	999 512	1 000 040	957 218	917 982	860 242	822 496	786 292
PP&E Gross	211 542	240 974	261 091	275 031	261 468	256 845	259 377	327 872	415 734	598 936	790 052	900 317	999 512	1 000 040	957 218	917 982	860 242	822 496	786 292
Accumulated Depreciation	73 620	99 232	120 945	146 237	176 899	203 636	227 591	248 149	268 792	299 731	325 725	357 172	383 908	435 110	517 056	565 260	634 906	726 280	808 602
Intangible Assets	40 260	49 933	56 140	76 742	77 950	78 071	80 035	87 862	67 151	40 068	45 704	60 690	66 244	72 886	80 170	84 587	81 045	94 136	113 278
Note Receivable	0	0	0	0	0	0	0	0	0	0	0	0	0	6 218	9 964	5 927	17 372	10 095	11 441
Long-Term Investments	104 235	105 308	141 360	81 611	68 566	62 195	67 926	50 778	43 749	27 460	72 825	71 928	90 914	59 874	53 108	72 863	45 049	176 285	129 557
Other Long-Term Assets	11 421	51 617	15 345	17 848	16 295	21 610	21 759	29 103	50 837	89 765	94 263	94 181	94 832	128 635	132 308	149 069	164 337	171 522	203 081
Total Assets	690 204 N/A	838 432 +21%	895 444 +7%	831 946 -7%	787 751 -5%	835 591 +6%	880 869 +5%	1 033 335 +17%	1 722 593 +67%	1 596 971 -7%	1 660 934 +4%	1 691 210 +2%	1 913 706 +13%	1 882 027 -2%	1 936 729 +3%	1 924 586 -1%	1 898 668 -1%	2 020 840 +6%	2 137 598 +6%
Liabilities
Accounts Payable	21 550	26 062	29 465	35 060	34 647	34 032	38 401	52 826	56 177	50 599	46 567	44 475	37 509	32 214	42 833	39 710	45 180	38 599	54 248
Accrued Liabilities	7 594	10 325	11 806	16 515	17 090	9 337	11 833	23 396	63 170	16 020	30 151	35 627	40 690	40 856	48 646	56 019	56 816	55 345	63 665
Short-Term Debt	200	55 279	62 651	138 464	103 145	90 821	103 851	35 556	37 484	77 418	170 212	201 500	213 100	238 100	255 900	369 100	336 100	370 600	319 500
Current Portion of Long-Term Debt	21 003	25 183	171 219	34 394	18 703	104 510	23 944	11 300	65 711	93 888	108 376	13 942	85 519	163 669	146 638	83 407	147 675	34 153	17 986
Other Current Liabilities	65 566	48 697	41 300	35 968	32 757	43 334	55 831	59 276	451 079	306 220	283 870	139 429	94 985	58 612	154 921	128 512	118 991	184 061	149 803
Total Current Liabilities	115 913	165 546	316 442	260 401	206 343	282 035	233 860	182 354	673 621	544 145	639 175	434 973	471 803	533 451	648 938	676 748	704 763	682 759	605 202
Long-Term Debt	175 154	235 818	82 391	147 527	179 178	118 038	153 105	225 357	264 231	160 915	197 654	415 751	552 948	400 419	301 100	225 816	89 092	91 934	96 726
Deferred Income Tax	15 322	4 734	11 859	3 929	3 894	3 947	3 345	2 905	2 909	2 946	921	311	1 571	452	0	0	0	0	0
Minority Interest	19 743	26 686	27 357	39 322	41 942	46 919	53 530	61 783	69 863	75 056	80 713	86 028	98 466	101 902	125 346	137 361	144 768	155 858	173 097
Other Liabilities	32 998	39 333	39 875	39 209	20 113	22 229	27 644	33 473	37 023	154 448	30 759	50 919	65 123	115 815	58 431	12 795	4 603	5 397	12 817
Total Liabilities	359 129 N/A	472 117 +31%	477 923 +1%	490 388 +3%	451 471 -8%	473 168 +5%	471 484 0%	505 872 +7%	1 047 648 +107%	937 509 -11%	949 223 +1%	987 982 +4%	1 189 911 +20%	1 152 039 -3%	1 133 815 -2%	1 052 720 -7%	943 226 -10%	935 947 -1%	887 841 -5%
Equity
Common Stock	20 746	21 745	22 782	17 886	18 780	19 718	20 703	24 361	25 577	26 088	27 909	28 464	29 030	29 608	30 196	30 795	31 405	32 027	32 027
Retained Earnings	263 592	329 852	375 859	15 887	14 434	8 235	49 878	79 683	228 143	228 894	285 290	287 801	323 771	334 117	396 916	452 297	581 979	680 888	836 489
Additional Paid In Capital	30 180	29 182	28 144	330 584	330 249	329 311	328 326	419 009	417 793	417 282	415 462	414 906	414 340	413 763	413 175	412 575	411 965	411 343	411 343
Unrealized Security Profit/Loss	33 907	7 034	32 619	11 033	934	7 781	13 004	5 476	3 259	1 211	8 810	4 698	9 287	11 400	22 035	4 688	35 801	41 533	44 266
Treasury Stock	14 196	22 267	44 764	411	706	880	1 228	1 745	2 153	9 280	15 730	21 318	25 185	28 268	33 142	36 976	40 047	43 327	43 327
Other Equity	3 154	769	2 881	1 647	1 457	1 741	1 298	678	2 326	2 312	10 029	11 323	8 874	7 832	17 804	8 486	5 941	45 495	57 489
Total Equity	331 076 N/A	366 316 +11%	417 521 +14%	341 558 -18%	336 280 -2%	362 424 +8%	409 385 +13%	527 463 +29%	674 945 +28%	659 461 -2%	711 711 +8%	703 228 -1%	723 795 +3%	729 987 +1%	802 914 +10%	871 866 +9%	955 442 +10%	1 084 893 +14%	1 249 756 +15%
Total Liabilities & Equity	690 204 N/A	838 432 +21%	895 444 +7%	831 946 -7%	787 751 -5%	835 591 +6%	880 869 +5%	1 033 335 +17%	1 722 593 +67%	1 596 971 -7%	1 660 934 +4%	1 691 210 +2%	1 913 706 +13%	1 882 027 -2%	1 936 729 +3%	1 924 586 -1%	1 898 668 -1%	2 020 840 +6%	2 137 598 +6%
Shares Outstanding
Common Shares Outstanding	12	13	13	11	11	11	11	11	12	12	12	12	12	12	12	12	12	13	13

Income Statement Balance Sheet Cash Flow Statement

Hanmi Pharm Co Ltd
KRX:128940

Balance Sheet

Balance Sheet Decomposition
Hanmi Pharm Co Ltd

Balance Sheet
Hanmi Pharm Co Ltd

See Also

Company

Help

Tools

Stocks

Hanmi Pharm Co Ltd KRX:128940

Balance Sheet

Balance Sheet Decomposition Hanmi Pharm Co Ltd

Balance Sheet Hanmi Pharm Co Ltd

See Also

Company

Help

Tools

Stocks

Hanmi Pharm Co Ltd
KRX:128940

Balance Sheet Decomposition
Hanmi Pharm Co Ltd

Balance Sheet
Hanmi Pharm Co Ltd